Comment on Wyeth osteoporosis drug set for Europe

Wyeth osteoporosis drug set for Europe

Collegeville-based Wyeth Pharmaceuticals announced today that the European Commission has granted marketing authorization for Conbriza, which treats postmenopausal osteoporosis.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News